Skip to main content
. 2009 Jun 29;53(9):3803–3814. doi: 10.1128/AAC.00263-09

FIG. 2.

FIG. 2.

(A) Scheme for the 10-week antiviral efficacy study with daily p.o. MIV-210 doses of 20 mg/kg and 60 mg/kg. (B) Scheme for the 4-week antiviral induction and 6-week maintenance study. MIV-210 was given at 10 mg/kg/day p.o. for the first 4 weeks and then for 6 weeks either at 10 mg/kg p.o. every third day (10 mg/kg/3d) or at 5.0 mg/kg daily.